MRI Protocol for Left Renal Mass
Order an MRI abdomen without and with IV contrast for optimal characterization of a left renal mass. 1
Recommended Protocol Components
The optimal MRI protocol should include the following sequences 2, 3:
- T1-weighted imaging with in-phase and opposed-phase (chemical shift) sequences to detect microscopic fat, which helps identify angiomyolipomas 2
- T2-weighted imaging to assess cyst characteristics and differentiate solid from cystic components 1, 2
- Dynamic contrast-enhanced T1-weighted sequences including multiple phases:
- Subtraction images to accurately assess enhancement in intrinsically hyperintense lesions 1, 2
- Diffusion-weighted imaging (DWI) to help differentiate benign from malignant masses and characterize RCC subtypes 1
Why MRI Without AND With Contrast is Critical
MRI without and with IV contrast provides superior diagnostic accuracy compared to either alone. 1
- Enhancement detection is the key feature for distinguishing benign from malignant masses, with a 15% enhancement threshold being optimal for differentiating cysts from solid tumors 1
- MRI demonstrates higher specificity than CT (68.1% vs 27.7%) while maintaining equivalent sensitivity (91.8% vs 94.5%) for diagnosing renal cell carcinoma 1
- MRI is more sensitive for detecting enhancement in masses with indeterminate enhancement on CT 1
- MRI is superior for small lesions <1.5 cm because it avoids pseudoenhancement artifacts that limit CT accuracy 1
What MRI Can Accomplish Without Contrast (If Contraindicated)
If gadolinium-based contrast is contraindicated, MRI without IV contrast still provides valuable diagnostic information 1:
- Simple cysts can be characterized on T2-weighted imaging by their homogeneous, very high T2 signal intensity 1
- Hemorrhagic or proteinaceous cysts can be differentiated from RCC when they show homogenous high T1 signal with smooth borders and lesion-to-renal parenchyma ratio >1.6 1
- Angular interface with renal parenchyma on T2-weighted imaging is 78% sensitive and 100% specific for benign exophytic masses 1
- Diffusion-weighted imaging may help differentiate solid RCC from oncocytomas, though less accurately than contrast-enhanced MRI 1
Clinical Decision Algorithm
For patients WITHOUT contrast contraindications:
- Order MRI abdomen without and with IV contrast as the primary study 1
- This is equivalent to CT abdomen without and with IV contrast per ACR guidelines 1
For patients with iodinated contrast allergy but NO gadolinium contraindication:
- MRI abdomen without and with IV contrast is the preferred alternative 1
For patients with BOTH iodinated AND gadolinium contraindications:
- Consider MRI abdomen without IV contrast or contrast-enhanced ultrasound with microbubbles 1
- Recognize that diagnostic yield will be reduced 1
Important Caveats and Pitfalls
- MRI has limited ability to detect calcifications compared to CT, though calcifications have reduced significance in the updated Bosniak 2019 classification 1
- 3.0T MRI may upgrade Bosniak classifications compared to 1.5T, so serial follow-up should use consistent field strength 1
- MRI may detect additional findings (increased septa, wall thickness, enhancement) not visible on CT, potentially upgrading cystic lesions and altering management 1, 5
- Nondiagnostic results remain possible, particularly for very small masses, and cannot be considered evidence of benignity 1